Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Alpha-GPC vs Saffron: Saffron has the stronger overall evidence (7.5 vs 7/10); they're alternatives for brain aging support — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Saffron wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 5 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Alpha-GPC and Saffron have evidence — compare verdict strength side-by-side.
300-600mg daily (a typical label dose, not the dose used in the cited trial, which gave a single 1,000 mg intramuscular dose)
Morning for cognitive enhancement, 30-60 min before workout for performance
Alpha-GPC 50% powder or capsules
28-30mg daily
Morning or split AM/PM
Affron® standardized extract
1-2 hours
2-4 weeks
Acute
Same day
4-8 weeks
4-8 weeks
2 menstrual cycles
L-Alpha-Glycerylphosphorylcholine (L-α-GPC): A Comprehensive Review of Its Preparation Techniques and Versatile Biological Effects
Journal of food science (2025) · Review
Due to its high choline content (41% by weight) and ability to cross the blood-brain barrier, GPC is considered one of the most utilized sources of choline.
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
Journal of Alzheimer's disease : JAD (2023) · Meta analysis
We found significant effects of α-GPC in combination with donepezil on cognition [4 RCTs, mean difference (MD):1.72, 95% confidence interval (CI): 0.20 to 3.25], functional outcomes [3 RCTs, MD:0.79, 95% CI: 0.34 to 1.23], and behavioral outcomes [4 RCTs; MD: -7.61, 95% CI: -10.31 to -4.91].
Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
The International journal of neuroscience (2013) · Review
Choline alphoscerate (alpha-glyceryl-phosphorylcholine, alpha-GPC) is a semisynthetic derivative of phosphatidylcholine with central parasympathomimetic action.
Comparative efficacy and tolerability of nutraceuticals for depressive disorder: A systematic review and network meta-analysis
Psychological medicine (2025) · Meta analysis · n=17437
Hundred and ninety-two trials involving 17,437 patients and 44 nutraceuticals were eligible for inclusion.
Systematic Review and Network Meta-Analysis of the Effects of Plant Extracts on Cognitive Function and Quality of Life in Stroke Patients
Phytotherapy research : PTR (2025) · Meta analysis · n=6599
48 eligible randomized controlled trials were included, covering 6599 stroke patients and evaluating nine different plant extract treatments, one of which was Crocus sativus (saffron).
New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms
Phytotherapy research : PTR (2024) · Systematic review
A random-effects or fixed-effects model was used to calculate the pooled effect sizes.
Both points come from one placebo-controlled crossover trial of single doses in 20 resistance-trained men (PMID 39683633): Stroop scores improved more than placebo after 315 mg (d = 0.48) and 630 mg (d = 0.61), while the Flanker and N-Back tests did not change. Taken daily for 7 days, 250 and 500 mg did not change psychomotor vigilance in 48 young men (PMID 29042830). In older people with type 2 diabetes and mild cognitive decline, 1,200 mg a day raised MMSE against placebo at 12 months but not at 6 months (PMID 39703111). No trial compared chronic doses.
Both points are doses of a standardised saffron extract (affron) in adults with low mood. A 4-week RCT in 128 adults (PMID 28735826) gave 22 or 28 mg a day: mood improved at 28 mg (POMS total mood disturbance versus placebo, d = -1.10) with no effect at 22 mg. A 12-week RCT in 202 adults with subclinical depressive symptoms (PMID 40414301) confirmed a smaller benefit at 28 mg (DASS-21 depression, d = 0.39). Doses above 28 mg were not compared with lower ones in these trials, so no optimal dose or safety ceiling is plotted. The cited depression meta-analyses pool trials without comparing doses.
AI-estimated from published studies. Interpret as directional guidance.
Saffron has a higher evidence score (7.5/10 vs 7/10) and wins in 3 of 3 categories.
For brain aging support, Saffron has a higher relevance score (70 vs 20).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Caffeine+L-theanine works; bacopa needs weeks; most "brain pills" are hype. The honest tier list.
Saffron, EPA omega-3, SAMe have real adjunct evidence — but these aren’t a substitute for care, and some interact dangerously.
Ashwagandha, L-theanine, magnesium, saffron — what actually helps stress, and the safety caveats.
The transition years (40s): cycle changes, mood, sleep, brain fog — foundations, vitex, and starting muscle work early.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.